Local study confirms safety, efficacy of Cardura XL

Published: 2004-09-06 06:59:00

Updated: 2004-09-06 06:59:00

The Korean Urological Association said in its recent issue that a local study affirmed that Pfizer Korea's Cardura XL (doxazosin mesylate) is safe and effective for its indications of high blood pressure and benign prostatic hyperplasia in Korean patients.

The association further noted that Ca...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK